MedPath

Catch the cancer; towards a cfDNA-based test for colorectal cancer screening

Completed
Conditions
colorectal cancer
colorectal carcinoma
10018018
10017990
10017991
Registration Number
NL-OMON48193
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

Individuals participating in the Dutch national colorectal cancer screening program who:
- Have a positive FIT (fecal immunohistochemical test), prior to sequential colonoscopy (performed in the Erasmus MC);
- Grant informed consent to participate in this study;;Lynch Syndrome carriers under surveillance of gastroenterologists in the Erasmus MC, who:
- Have proven Lynch syndrome (DNA mismatch repair mutation);
- Are >=18 years;
- Grant informed consent to participate in this study.

Exclusion Criteria

Individuals participating in the Dutch national colorectal cancer screening program who:
- Are known to be carrier of a genetic predisposition for colorectal cancer (for example Familial Adenomatous Polyposis or MUTYH Associated Polyposis);
- Have a negative FIT;
- Have a positive FIT with sequential colonoscopy already performed;
- Are unwilling to undergo colonoscopy or receive unexpected, but relevant and actionable findings;
- Underwent a failed colonoscopy;;Lynch Syndrome carriers who:
- Are unwilling to undergo colonoscopy or receive unexpected, but relevant and actionable findings;
- are <18 years;
- underwent a failed colonoscopy.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The agreement between cfDNA profiles and DNA profiles of corresponding lesions<br /><br>found during regular colonoscopy. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p> The extent of psychological burden caused by this screening tool.</p><br>
© Copyright 2025. All Rights Reserved by MedPath